ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MAIA vs LFVN // RSI-14 & 200D SMA MOMENTUM

MAIA Biotechnology Inc. (NYSE) VS. Lifevantage Corporation (Delaware) (NASDAQ) • 15-METRIC TALLY: MAIA 0 — LFVN 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: LFVN
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MAIA VS. LFVN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MAIA LFVN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 80.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 29.20% -64.20 LFVN /roic <GO>
EV/EBITDA & P/E Valuation — 5.5x — TIE /valuation <GO>
Free Cash Flow Yield — 14.22% — TIE /fcf-yield <GO>
Operating Margin — 5.30% — TIE /operating-margins <GO>
Net Profit Margin — 4.30% — TIE /net-margins <GO>
Revenue Growth (YoY) — 14.20% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.80% -2.80 LFVN /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.98 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 LFVN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 45.2 49.6 -4.45 LFVN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 6.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $72.9M $73.9M -$1.0M LFVN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MAIA REV LFVN REV MAIA GROSS % LFVN GROSS % MAIA FCF LFVN FCF
FY 2025 $0 $228.5M — 80.4% -$18.8M $10.5M
FY 2024 $0 $200.2M — 79.3% -$15.7M $10.0M
FY 2023 — $213.4M — — — $6.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MAIA // BETA —
LFVN // BETA —